Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DTYMK | P23919 | 1/20 | 0.53 |
| ▸ | LCK | P06239 | 1/20 | 0.46 |
| ▸ | FYN | P06241 | 1/20 | 0.46 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.41 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.41 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA3 | P07451 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | CA6 | P23280 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7207048 | 0.84 | MCL1 (0.65) | DTYMKLCKFYNMCL1HSD17B10 | |
| SCHEMBL9206001 | 0.80 | DTYMK (0.58) | DTYMKMCL1HSD17B10CYP1A2CYP2C9 | |
| SCHEMBL23141167 | 0.80 | LMNA (0.51) | LCKFYNMCL1HSD17B10TSHR | |
| SCHEMBL739200 | 0.77 | MCL1 (0.71) | DTYMKLCKMCL1HSD17B10CYP2C9 | |
| SCHEMBL570906 | 0.76 | KDM4E (0.63) | LCKFYNHSD17B10CYP1A2CYP2C9 | |
| SCHEMBL2895327 | 0.75 | ALDH1A1 (0.61) | DTYMKMCL1HSD17B10CYP1A2CYP2C9 | |
| SCHEMBL8163290 | 0.74 | KDM4E (0.61) | LCKFYNHSD17B10CYP1A2CYP2C9 | |
| SCHEMBL7263165 | 0.74 | CA12 (0.61) | LCKFYNHSD17B10TSHRPTPN1 | |
| SCHEMBL70653 | 0.74 | KDM4E (0.52) | LCKFYNHSD17B10HPGDTSHR | |
| SCHEMBL14514252 | 0.72 | HSD17B10 (0.44) | LCKFYNHSD17B10CYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8854617-B2 | Compounds and markers for surface-enhanced Raman scattering | JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG (DE) | 2014-10-07 | — | — | US | disclosed |
| EP-2193374-B1 | MARKERS FOR SURFACE-ENHANCED RAMAN SCATTERING | UNIV WUERZBURG J MAXIMILIANS (DE) | 2013-10-23 | — | — | EP | disclosed |
| US-20100284917-A1 | COMPOUNDS AND MARKERS FOR SURFACE-ENHANCED RAMAN SCATTERING | JULIUS-MAXIMILIANS- UNIVERSITAT (DE) | 2010-11-11 | — | — | US | disclosed |
| EP-2193374-A2 | COMPOUNDS AND MARKERS FOR SURFACE-ENHANCED RAMAN SCATTERING | Julius-Maximilians-Universität Würzburg (DE) | 2010-06-09 | — | — | EP | disclosed |
| WO-2009040114-A2 | COMPOUNDS AND MARKERS FOR SURFACE-ENHANCED RAMAN SCATTERING | JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG (DE) | 2009-04-02 | — | — | WO | disclosed |
| EP-2040075-A1 | Compounds and markers for surface-enhanced raman scattering | Julius-Maximilians-Universität Würzburg (DE) | 2009-03-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100284917-A1 | COMPOUNDS AND MARKERS FOR SURFACE-ENHANCED RAMAN SCATTERING | EPCAM, SELE, CD44 | DTYMK 4515/4885LCK 4480/4885FYN 4117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.